Cargando…

Erratum in: Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2022
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055554/ https://www.ncbi.nlm.nih.gov/pubmed/35467691 http://dx.doi.org/10.1167/iovs.63.4.16

Ejemplares similares

Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro
por: Narayana, Revu V. L., et al.
Publicado: (2021)

Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
por: Mitra, Moutushy, et al.
Publicado: (2011)

Erratum: Cultivation of Retinoblastoma Cells: Correlation Between In Vitro Growth Pattern and Histopathology
Publicado: (2017)

Erratum: Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma
por: Delrish, Elham, et al.
Publicado: (2022)

Erratum: Intra-arterial chemotherapy in retinoblastoma – A paradigm change
Publicado: (2019)

Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer: A Multicenter Phase 2 Study: Erratum
Publicado: (2015)

Tumor Theranostics of Transition Metal Ions Loaded Polyaminopyrrole Nanoparticles: Erratum
por: Li, Shuyao, et al.
Publicado: (2022)

Carboplatin/etoposide: Neutropenia and thrombocytopenia: case report
Publicado: (2021)

Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo
por: Zhou, Zijun, et al.
Publicado: (2020)

Docetaxel-Loaded Solid Lipid Nanoparticles Suppress Breast Cancer Cells Growth with Reduced Myelosuppression Toxicity [Erratum]
Publicado: (2019)

Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: An animal trial
por: Shome, Debraj, et al.
Publicado: (2014)

Erratum to: ‘Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial
por: Yardley, Denise A., et al.
Publicado: (2016)

Erratum: Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells
por: Curtin, Joshua C., et al.
Publicado: (2018)

Erratum to: Quantification of the cellular dose and characterization of nanoparticle transport during in vitro testing
por: Rischitor, Grigore, et al.
Publicado: (2016)

NAC-loaded electrospun scaffolding system with dual compartments for the osteogenesis of rBMSCs in vitro [Erratum]
Publicado: (2019)

Erratum: Cancer stem cells in melanoma
por: Regenbrecht, C, et al.
Publicado: (2012)

Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy”
Publicado: (2021)

Erratum to: “Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma”
por: Quiñonez-Silva, Guadalupe, et al.
Publicado: (2017)

Undetactable levels of genotoxicity of SiO(2) nanoparticles in in vitro and in vivo tests [Erratum]
Publicado: (2015)

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
por: Li, Yue-Ya, et al.
Publicado: (2015)

Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines
por: Busch, Maike, et al.
Publicado: (2018)

Inhibitory effect of carboplatin in combination with bevacizumab on human retinoblastoma in an in vitro and in vivo model
por: Zhang, Qi, et al.
Publicado: (2017)

Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site
por: Piga, A, et al.
Publicado: (2004)

A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
por: McClay, E. F., et al.
Publicado: (1993)

Erratum to changes in the hepatic differentiation potential of human mesenchymal stem cells aged in vitro
Publicado: (2022)

Erratum to: Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer
por: Kataoka, Nobutaka, et al.
Publicado: (2020)

Erratum to: NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin
por: Suwei, Dong, et al.
Publicado: (2016)

Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles
por: Xia, Xiaojing, et al.
Publicado: (2017)

Erratum to: Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer’s Disease
por: Wei, Hui, et al.
Publicado: (2020)

Carboplatin +/− Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma
por: Francis, Jasmine H., et al.
Publicado: (2013)

Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines
por: Cho, Chang Sik, et al.
Publicado: (2022)

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
por: English, M. W., et al.
Publicado: (1996)

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
por: Imaya, Masayuki, et al.
Publicado: (2022)

Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
por: Torka, Pallawi, et al.
Publicado: (2022)

Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide
por: Biasoli, D, et al.
Publicado: (2013)

Anti-CD30-targeted gold nanoparticles for photothermal therapy of L-428 Hodgkin’s cell [Erratum]
Publicado: (2013)

Erratum to: Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling
por: Pandian, Vijayabaskar, et al.
Publicado: (2016)

Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
por: Li, Fan, et al.
Publicado: (2020)

Erratum: An intrinsic mechanism controls reactivation of neural stem cells by spindle matrix proteins
por: Li, Song, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pgnr4m2k87j00vn7us721b428n